Principal Financial Group Inc G1 Therapeutics, Inc. Transaction History

Principal Financial Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$13.16 - $22.47 $127,480 - $217,666	-9,687 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$19.57 - $26.32 $24,247 - $32,610	1,239 Added 14.67%	9,687 $212,000
Q1 2021 May 10, 2021	BUY	$17.58 - $32.59 $148,515 - $275,320	8,448 New	8,448 $203,000
Q4 2018 Feb 14, 2019	SELL	$16.51 - $51.33 $137,148 - $426,398	-8,307 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$43.15 - $67.97 $358,447 - $564,626	8,307 New	8,307 $435,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.